The ribonucleasel-dependent antiviral roles of human 2′,5′-oligoadenylate synthetase family members against hepatitis C virus

Modulation of the type I interferon pathways by culture-adaptive hepatitis C virus core mutants

(2012) Ju-Il Kang et al.   FEBS LETTERS

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication

(2012) Philippe Metz et al.   HEPATOLOGY

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy

(2010) Mostafa K El Awady et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

New Insights into the Role of RNase L in Innate Immunity

(2010) Arindam Chakrabarti et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

The Oligoadenylate Synthetase Family: An Ancient Protein Family with Multiple Antiviral Activities

(2010) Helle Kristiansen et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP

(2010) K. Malathi et al.   RNA

Distinct Antiviral Roles for Human 2',5'-Oligoadenylate Synthetase Family Members against Dengue Virus Infection

(2009) R.-J. Lin et al.   JOURNAL OF IMMUNOLOGY

Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression

(2009) Michael Kulka et al.   VIROLOGY

PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control

(2009) Ju-Il Kang et al.   VIRUS RESEARCH

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

(2009) Jean K. Lim et al.   PLoS Pathogens